Iterum Therapeutics (ITRM) Institutional Ownership → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free ITRM Stock Alerts $1.44 -0.01 (-0.69%) (As of 04/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Iterum Therapeutics (NASDAQ:ITRM)CurrentInstitutional OwnershipPercentage9.21%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$214KNumber ofInstitutional Sellers(last 12 months)0 Get ITRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ITRM Institutional Buying and Selling by Quarter Ad Crypto 101 Media[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Iterum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/4/2023Apollon Wealth Management LLC200,000$214K0.0%N/A1.542% 11/14/2022Renaissance Technologies LLC34,684$56K0.0%-89.3%0.284% 11/10/2022New Leaf Venture Partners L.L.C.97,084$157K0.1%-93.3%0.794% 11/10/2022Dimensional Fund Advisors LP62,301$101K0.0%N/A0.509% 10/6/2022Krilogy Financial LLC20,000$32K0.0%-90.0%0.163% 8/18/2022Goldman Sachs Group Inc.304,684$61K0.0%N/A0.166% Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/13/2022Renaissance Technologies LLC323,300$65K0.0%+199.1%0.176% 8/12/2022Franklin Resources Inc.258,778$52K0.0%-32.6%0.141% 7/14/2022Krilogy Financial LLC200,000$40K0.0%N/A0.109% 5/17/2022Virtu Financial LLC282,841$100K0.0%-32.4%0.155% 11/16/2021Squarepoint Ops LLC52,503$29K0.0%+106.9%0.029% 11/15/2021Franklin Resources Inc.384,200$215K0.0%N/A0.210% 11/12/2021Renaissance Technologies LLC644,567$360K0.0%-80.4%0.353% 10/25/2021Krilogy Financial LLC81,000$45K0.0%+161.3%0.044% 9/17/2021Virtu Financial LLC83,658$193K0.0%-37.2%0.046% 8/17/2021Millennium Management LLC2,560,381$5.91M0.0%+3,304.5%1.429% 8/16/2021Squarepoint Ops LLC25,382$59K0.0%-49.4%0.014% 8/16/2021Cubist Systematic Strategies LLC89,431$207K0.0%N/A0.050% 8/13/2021Renaissance Technologies LLC3,289,300$7.60M0.0%N/A1.836% 8/13/2021Sigma Planning Corp17,153$40K0.0%N/A0.010% 8/13/2021QS Investors LLC384,200$888K0.0%N/A0.214% 8/12/2021Insight Advisors LLC PA35,000$28K0.0%-88.5%0.020% 8/11/2021Susquehanna Fundamental Investments LLC66,230$153K0.0%N/A0.037% 8/10/2021National Asset Management Inc.32,100$75K0.0%-61.0%0.018% 8/4/2021Grimes & Company Inc.146,278$338K0.0%+17.4%0.082% 7/15/2021Focused Wealth Management Inc100,000$231K0.0%+33.3%0.056% 5/21/2021Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/19/2021Virtu Financial LLC133,197$188K0.0%+209.0%0.074% 5/19/2021Squarepoint Ops LLC50,196$71K0.0%N/A0.028% 5/18/2021Millennium Management LLC75,206$106K0.0%N/A0.042% 5/18/2021Verition Fund Management LLC112,500$159K0.0%N/A0.063% 5/18/2021Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/18/2021Jane Street Group LLC18,041$25K0.0%N/A0.010% 5/17/2021Royal Bank of Canada19,000$27K0.0%N/A0.011% 5/17/2021Edmond DE Rothschild Holding S.A.100,000$141K0.0%N/A0.056% 5/17/2021HRT Financial LP399,479$563K0.0%+3,875.3%0.223% 5/13/2021Barclays PLC50,000$71K0.0%N/A0.028% 5/12/2021Geode Capital Management LLC96,173$135K0.0%+190.4%0.054% 5/12/2021Grimes & Company Inc.124,637$176K0.0%+73.1%0.070% 5/12/2021FineMark National Bank & Trust300,000$423K0.0%N/A0.167% Bitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is.5/12/2021UBS Group AG52,961$75K0.0%N/A0.030% 5/4/2021Commonwealth Equity Services LLC18,500$26K0.0%N/A0.010% 2/25/2021Clear Street Markets LLC55,000$54K0.0%N/A0.045% 2/24/2021Virtu Financial LLC43,111$43K0.0%N/A0.036% 2/10/2021Renaissance Technologies LLC732,900$725K0.0%N/A1.493% 2/9/2021Pivotal bioVenture Partners Investment Advisor LLC945,085$935K0.3%N/A1.926% 2/3/2021Focused Wealth Management Inc75,000$74K0.0%N/A0.153% 2/2/2021Grimes & Company Inc.72,000$71K0.0%N/A0.147% 5/12/2020Granahan Investment Management Inc. MA241,121$653K0.0%-1.4%1.672% 5/11/2020Ensign Peak Advisors Inc189,853$515K0.0%-17.7%1.317% 5/1/2020UBS Group AG12,492$34K0.0%+542.3%0.089% (Data available from 1/1/2016 forward) ITRM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ITRM shares? During the previous two years, the following institutional investors and hedge funds held shares of Iterum Therapeutics shares: Apollon Wealth Management LLC ($214K), New Leaf Venture Partners L.L.C. ($157K), Dimensional Fund Advisors LP ($101K), Virtu Financial LLC ($100K), Goldman Sachs Group Inc. ($61K), Renaissance Technologies LLC ($56K), and Franklin Resources Inc. ($52K).Learn more on ITRM's institutional investors. What percentage of Iterum Therapeutics stock is owned by institutional investors? 9.21% of Iterum Therapeutics stock is owned by institutional investors. Learn more on ITRM's institutional investor holdings. Which institutional investors have been buying Iterum Therapeutics stock? The following institutional investors have purchased Iterum Therapeutics stock in the last 24 months: Goldman Sachs Group Inc. ($304.68K), Renaissance Technologies LLC ($215.20K), Krilogy Financial LLC ($200K), Apollon Wealth Management LLC ($200K), and Dimensional Fund Advisors LP ($62.30K). How much institutional buying is happening at Iterum Therapeutics? Institutional investors have bought a total of 982,185 shares in the last 24 months. This purchase volume represents approximately $2.48M in transactions. Which Iterum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Iterum Therapeutics stock in the last 24 months: New Leaf Venture Partners L.L.C. ($1.36M), Renaissance Technologies LLC ($288.62K), Krilogy Financial LLC ($180K), Virtu Financial LLC ($135.47K), and Franklin Resources Inc. ($125.42K). How much institutional selling is happening at Iterum Therapeutics? Institutional investors have sold a total of 2,088,726 shares in the last 24 months. This volume of shares sold represents approximately $4.06M in transactions. Related Companies: Lisata Therapeutics Major Shareholders Addex Therapeutics Major Shareholders DURECT Major Shareholders Oncternal Therapeutics Major Shareholders Indaptus Therapeutics Major Shareholders Bullfrog AI Major Shareholders Sensei Biotherapeutics Major Shareholders NeuroSense Therapeutics Major Shareholders Biora Therapeutics Major Shareholders Unity Biotechnology Major Shareholders This page (NASDAQ:ITRM) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeUrgent alert: open this for a huge profit potentialTimothy SykesTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBiden out June 13; Kamala won’t replace him?Paradigm PressThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.